Long-term survival for a cohort of adults with cerebral palsy
- PMID: 16417662
- DOI: 10.1017/S0012162206000211
Long-term survival for a cohort of adults with cerebral palsy
Abstract
The aim of this study was to investigate long-term survival and examine causes of death in adult patients with cerebral palsy (CP). A 1940-1950 birth cohort based on paediatric case referral allows for long-term survival follow-up. Survival is analyzed by birth characteristics and severity of disability from age 20 years (and age 2y for a subset of the data). Survival outcome compared with that expected in the general population based on English life tables. The main cohort consisted of 341 individuals, with 193 males and 148 females. Conditional on surviving to age 20 years, almost 85% of the cohort survived to age 50 years (a comparable estimate for the general population is 96%). Very few deaths were attributed to CP for those people dying over 20 years of age. Females survived better than males. However, females faced a greater increase in risk relative to the general population than did males. We conclude that survival outlook is good though lower than in the general population. The relative risk of death compared with the UK population decreases with age, although it shows some indication of rising again after age 50 years. Many more deaths were caused by diseases of the respiratory system among those dying in their 20s and 30s than would be expected in the general population. Many fewer deaths than expected in this age group are caused by injuries and accidents. For those people who die in their 40s and 50s, an increase in deaths due to diseases of the circulatory system and neoplasms is observed. More deaths than expected in this age group are due to diseases of the nervous system.
Similar articles
-
Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index.BMC Neurol. 2019 Jun 4;19(1):111. doi: 10.1186/s12883-019-1343-1. BMC Neurol. 2019. PMID: 31164086 Free PMC article.
-
Life expectancy among people with cerebral palsy in Western Australia.Dev Med Child Neurol. 2001 Aug;43(8):508-15. doi: 10.1017/s0012162201000949. Dev Med Child Neurol. 2001. PMID: 11508916
-
Effect of severity of disability on survival in north east England cerebral palsy cohort.Arch Dis Child. 2000 Dec;83(6):468-74. doi: 10.1136/adc.83.6.468. Arch Dis Child. 2000. PMID: 11087278 Free PMC article.
-
Life expectancy in severe cerebral palsy.Arch Dis Child. 2006 Mar;91(3):254-8. doi: 10.1136/adc.2005.075002. Arch Dis Child. 2006. PMID: 16492890 Free PMC article. Review.
-
Cerebral palsy life expectancy.Clin Perinatol. 2006 Jun;33(2):545-55. doi: 10.1016/j.clp.2006.03.016. Clin Perinatol. 2006. PMID: 16765736 Review.
Cited by
-
Assessing cancer in people with profound and multiple disabilities.BMC Cancer. 2023 Aug 25;23(1):798. doi: 10.1186/s12885-023-11313-3. BMC Cancer. 2023. PMID: 37626285 Free PMC article.
-
Exploring the Perspectives of Adults Aging With Long-Term Physical Disabilities on Physical Activity: A Qualitative Study.Am J Health Promot. 2023 Jun;37(5):654-663. doi: 10.1177/08901171221151123. Epub 2023 Jan 9. Am J Health Promot. 2023. PMID: 36624040 Free PMC article.
-
5-year risk of "adult-onset" chronic diseases during childhood and adolescent transitioning for individuals with cerebral palsy.Prev Med Rep. 2022 Jul 28;29:101933. doi: 10.1016/j.pmedr.2022.101933. eCollection 2022 Oct. Prev Med Rep. 2022. PMID: 35928595 Free PMC article.
-
Physical and occupational therapy utilization and associated factors among adults with cerebral palsy: Longitudinal modelling to capture distinct utilization groups.Disabil Health J. 2022 Jul;15(3):101279. doi: 10.1016/j.dhjo.2022.101279. Epub 2022 Feb 15. Disabil Health J. 2022. PMID: 35264292 Free PMC article.
-
Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.J Manag Care Spec Pharm. 2021 Jan;27(1):51-63. doi: 10.18553/jmcp.2021.27.1.051. J Manag Care Spec Pharm. 2021. PMID: 33377441 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
